NCT06994234View on ClinicalTrials.gov

Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 20, 2027

Study Completion Date

June 20, 2028

Conditions
Metabolic Dysfunction-Associated Steatotic Liver Disease
Interventions
BEHAVIORAL

In-Place Slow Jogging

ultra-jogging training was carried out 5 times a week, and each training session lasted for 30 minutes.

Trial Locations (1)

200120

Shanghai East Hospital, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER

NCT06994234 - Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease | Biotech Hunter | Biotech Hunter